Insmed to present at the nasdaq 49th investor conference

Bridgewater, n.j. , nov. 29, 2023 /prnewswire/ -- insmed incorporated (nasdaq: insm), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the nasdaq 49th investor conference in london on wednesday, december 6, 2023, at 8:30 a.m.
INSM Ratings Summary
INSM Quant Ranking